New blood thinner 'antidote' to help doctors move past warfarin
NEW YORK (Reuters) - A new class of blood thinners that competes with widely used warfarin should get a boost next year when an "antidote" that can reverse the medications' effects in an emergency is expected to enter the market, according to top U.S. heart doctors and investors.
Aucun commentaire:
Enregistrer un commentaire